Multiple Sclerosis Clinical Trial
Official title:
Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)
| NCT number | NCT01381354 |
| Other study ID # | 200911781 |
| Secondary ID | |
| Status | Completed |
| Phase | Phase 1 |
| First received | |
| Last updated | |
| Start date | October 2010 |
| Est. completion date | May 2016 |
| Verified date | June 2018 |
| Source | University of Iowa |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The study will use a multimodal therapeutic lifestyle intervention consisting of a study diet, stressing more vegetables and fruit, elimination of foods at greatest risk for food allergy, meditation, self massage, progressive exercise and neuromuscular electrical stimulation for rehabilitation of gait and fatigue disability in the setting of secondary and primary progressive multiple sclerosis with gait disability.
| Status | Completed |
| Enrollment | 38 |
| Est. completion date | May 2016 |
| Est. primary completion date | February 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - Secondary or primary progressive multiple sclerosis - Some level of gait disability - Tolerance for test electrical therapy session - Successful completion of two week Run-IN phase completing the daily logs - - Demonstrating > 80% compliance with dietary and behavioral interventions Exclusion Criteria: - Antiplatelet or blood thinning medication - Cognitive disability or psychiatric disorder making compliance with study interventions difficult - Implanted electronic medical device - Change in medication in the prior three months - Active cancer treatment (skin basal cell or squamous cancer is not an exclusion criteria) |
| Country | Name | City | State |
|---|---|---|---|
| United States | Univeristy of Iowa/ VA Iowa City VA Medical Center | Iowa City | Iowa |
| Lead Sponsor | Collaborator |
|---|---|
| University of Iowa | Direct MS Canada, DJO Incorporated, Pinnaclife Inc., TZ Press, LLC |
United States,
Reese D, Shivapour ET, Wahls TL, Dudley-Javoroski SD, Shields R. Neuromuscular electrical stimulation and dietary interventions to reduce oxidative stress in a secondary progressive multiple sclerosis patient leads to marked gains in function: a case report. Cases J. 2009 Aug 10;2:7601. doi: 10.4076/1757-1626-2-7601. — View Citation
Wahls TL, Reese D, Kaplan D, Darling WG. Rehabilitation with neuromuscular electrical stimulation leads to functional gains in ambulation in patients with secondary progressive and primary progressive multiple sclerosis: a case series report. J Altern Complement Med. 2010 Dec;16(12):1343-9. doi: 10.1089/acm.2010.0080. — View Citation
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Fatigue severity scale | Self reported fatigue severity scale, (agreement with 9 questions describing impact of fatigue on daily activities) | Baseline, 3 M, 6M, 9M,12 M | |
| Secondary | 25 foot walk | Average walking speed calculated from 25 foot walk. Distance (feet)walked divided by time in seconds. Step and stride length, step and stride duration. |
baseline, 3M, 6M, 9M, 12M, 18M, 24M 36M | |
| Secondary | Short Form 36 | Self reported function in multiple domains. | baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36 M | |
| Secondary | Mood scales | Beck depression index, Beck anxiety index | Baseline, 3 M, 6M, 9M, 12M | |
| Secondary | Cognitive Scales | Cognitive stability index or cognitive stability test, subscales of Dkef, Wtar, Wais III. | baseline, 3 M, 6M, 9M, 12 M | |
| Secondary | Medical Symptoms Questionnaire | Detailed review of systems which is scored 0 to 4 for each item. | baseline, 1 M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M, 18M, 24M, 36M | |
| Secondary | Side effects log | Questions about potential side effects from vitamin, supplements and diet, questions about potential side effects from NMES, and questions about potential side effects from exercise. | Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M | |
| Secondary | MS Function | Self reported disability scales (from North American Research committee on Multiple Sclerosis) | Baseline, 3 M, 6M, 9M, 12M, 18M, 24M, 36M | |
| Secondary | Multiple Sclerosis Spasticity Scale-88 | 88 Questions about the impact of spasticity on various activities of daily living | Baseline, 3M, 6M,9M and 12M, 18M, 24M, 36M | |
| Secondary | Daily log | Daily reports of foods consumed, exercises and activities completed. | Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M | |
| Secondary | Vitamin log | Log of vitamins supplement bottles date opened, date emptied, pill size, number of pills in bottle. | Baseline, 1M, 2M, 3M, 4M, 5M, 6M, 7M, 8M, 9M, 10 M, 11M, 12M | |
| Secondary | Medical examination | Medical examination | Baseline, 12 M | |
| Secondary | Neurological examination | Neurological examination | Baseline and 12 M | |
| Secondary | Exposure history form | History of exposures to chemicals. | Baseline | |
| Secondary | Health questions | health questions about chronic disease states | Baseline | |
| Secondary | Menses and pregnancy risk | Questions about menses and potential for pregnancy | Baseline, 3M, 6M, 9M, 12M | |
| Secondary | Medication audit | Medications | Baseline, 12 M | |
| Secondary | Functional diagnoses | Questions about past medical history | Baseline | |
| Secondary | Manual motor testing | Manual motor testing of arms, legs and core muscle groups. | Baseline, 3M, 6M, 9M, 12M | |
| Secondary | Berg Balance | Tests of balance which are progressively more challenging. | baseline, 3M, 6M, 9M, 12M | |
| Secondary | Modified Ashworth | Test of spasticity by physical examination. | baseline, 3M, 6M, 9M, 12M | |
| Secondary | Circumference | Circ. of waist, hips, R and+ L calf and R. and L. thigh. | baseline, 3M, 6M, 9M, 12M | |
| Secondary | Peak flow | Peak expiratory flow rate. | baseline, 3M, 6M, 9M, 12M | |
| Secondary | Number of falls in prior two months | Self reported number of falls and associated factors contributing to fall and severity of fall related injuries. | Baseline, 3M, 6M, 9M,12M, 18M, 24M, 36M | |
| Secondary | Dietary compliance | Assessments, self report, Harvard Food Frequency (baseline, 12 month), 24 hour dietary recalls (6M) | Baseline, 6 month and 12 month, 36 month | |
| Secondary | Blood pressure | blood pressure | baseline, 3M, 6M, 9M, 12M | |
| Secondary | Waist/ Hip ratio | circumference of waist over the circumference of hip | baseline, 3M, 6M, 9M, 12M | |
| Secondary | MS quality of life- 54 | Quality of life questionnaires asking about various aspects of daily life. | Baseline and months 3,6,9,12,18,24,and 36 | |
| Secondary | Blood Biomarkers | Blood biomarkers of inflammation, and nutritional status. | Baseline, 12 months | |
| Secondary | Change in functional and structural brain Magnetic Resonance Imaging (MRI) measures | Following sequences: T1 weighted - Pre Gadolinium T1 weighted -Post Gadolinium T2 weighted FLAIR functional MRI during cognitive task Resting state functional MRI Diffusion Tensor Imaging |
Between 1 and 12 month post intervention | |
| Secondary | Fatigue severity scale | Self reported fatigue severity scale, (agreement with 9 questions describing impact of fatigue on daily activities) | 18 M, 24 M, 36 M | |
| Secondary | Get up and go test time | Total time to get up from chair, walk 10 feet and come back and sit down on the chair. Step and stride length, step and stride duration and double support time. |
Baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36M | |
| Secondary | Change in weight and Body mass index (BMI) | weight measured in Kg Body mass index (BMI) | Baseline, 3M, 6M, 9M, 12M, 18M, 24M, 36M | |
| Secondary | Blood safety biomarkers | Kidney and liver function tests and complete blood count | Baseline, 1M, 3M, 6M, 9M, 12M, 18M, 24M, 36M | |
| Secondary | 9 hole peg board test | Time to put 9 pegs in holes and take them out. | Baseline, 3M, 6M, 9M,12M, 18M, 24M, 36M | |
| Secondary | Paced auditory serial addition task (PASAT) | Addition of two consecutive numbers during a series of numbers heard by subject. | Baseline, 3M, 6M,9M,12M, 18M,24M,36M | |
| Secondary | Veteran specific activity questionnaire | Questions about the maximum physical activity level. | Baseline, 3M, 6M, 9M, 12M, 18M,24M,36M | |
| Secondary | Form 38- Daily life | Questions about stressful life events. | 12M, 18M, 24M, 36M | |
| Secondary | Urine toxicology | 24 hours urine collection and measurement of heavy metals. | Baseline and 12 M | |
| Secondary | Stool microbial profile | DNA probe for bacteria, parasites and yeast DNA. | Baseline and 12M | |
| Secondary | Harvard food frequency questionnaire and 24 hour food recalls | Questions regarding food intake and frequency of type of food consumed in last one year. Phone interview asking about food consumed in last 24 hours. |
Baseline, 12M, 24M and 36M | |
| Secondary | Bio impedance analysis | Test to analyze body composition. | Baseline, 12M, 24M and 36M | |
| Secondary | Exercise and electrical stimulation daily log | Record of exercise, use of electrical stimulation on muscles and physical activity. | Daily baseline through 12M, 14 day-logs before/after 18M, 24M and 36M |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |